First human test: new Drug's safety check begins
NCT ID NCT06873724
Summary
This is the first study in humans to test the safety of a new drug called SPY003-207. It involves 59 healthy volunteers who receive a single dose to see how their bodies react and process the drug. The main goal is to check for side effects and understand how the drug moves through the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Spyre Site 1
Montreal, Quebec, H3P 3P1, Canada
-
Spyre Site 2
Cypress, California, 90630, United States
Conditions
Explore the condition pages connected to this study.